{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:51:53Z","timestamp":1776934313314,"version":"3.51.2"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":104,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.4158\/accr-2020-0191","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T18:13:28Z","timestamp":1600712008000},"page":"e269-e272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Severe Hypertriglyceridemia Associated With Everolimus Treatment After Heart Transplantation"],"prefix":"10.1016","volume":"6","author":[{"given":"Phillip","family":"Lo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Muir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Eisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter S.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/ACCR-2020-0191_bb0010","doi-asserted-by":"crossref","first-page":"683964","DOI":"10.1155\/2013\/683964","article-title":"Everolimus in heart transplantation: an update","volume":"2013","author":"Hirt","year":"2013","journal-title":"J Transplant"},{"key":"10.4158\/ACCR-2020-0191_bb0015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.trre.2014.03.002","article-title":"Strategies for the management of adverse events associated with mTOR inhibitors","volume":"28","author":"Kaplan","year":"2014","journal-title":"Transplant Rev"},{"key":"10.4158\/ACCR-2020-0191_bb0020","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2337\/db09-1324","article-title":"Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue","volume":"59","author":"Houde","year":"2010","journal-title":"Diabetes"},{"key":"10.4158\/ACCR-2020-0191_bb0025","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1399-0012.2007.00686.x","article-title":"Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients","volume":"21","author":"Tenderich","year":"2007","journal-title":"Clin Transplant"},{"key":"10.4158\/ACCR-2020-0191_bb0030","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ"},{"key":"10.4158\/ACCR-2020-0191_bb0035","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/ajg.2009.27","article-title":"Hypertriglyceridemic pancreatitis: presentation and management","volume":"104","author":"Tsuang","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.4158\/ACCR-2020-0191_bb0040","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ejca.2011.02.014","article-title":"Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma","volume":"47","author":"Porta","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.4158\/ACCR-2020-0191_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.6004\/jnccn.2013.0003","article-title":"Everolimus causing severe hypertriglyceridemia and acute pancreatitis","volume":"11","author":"Subramaniam","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"10.4158\/ACCR-2020-0191_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12882-016-0376-6","article-title":"Acute pancreatitis associated with everolimus after kidney transplantation: a case report","volume":"17","author":"Fontana","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.4158\/ACCR-2020-0191_bb0055","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MOL.0b013e3283319a1d","article-title":"Severe hypertriglyceridemia and pancreatitis: presentation and management","volume":"20","author":"Ewald","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"10.4158\/ACCR-2020-0191_bb0060","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2146\/ajhp110144","article-title":"Hypertriglyceridemia-induced acute pancreatitis treated with insulin and heparin","volume":"69","author":"Twilla","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"10.4158\/ACCR-2020-0191_bb0065","first-page":"293917","article-title":"Treatment of severe hypertriglyceridemia with continuous insulin infusion","volume":"2011","author":"Rodr\u00edguez Santana","year":"2011","journal-title":"Case Rep Crit Care"},{"key":"10.4158\/ACCR-2020-0191_bb0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MOL.0b013e32832d4a33","article-title":"Inherited lipodystrophies and hypertriglyceridemia","volume":"20","author":"Simha","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"10.4158\/ACCR-2020-0191_bb0075","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMcp070061","article-title":"Hypertriglyceridemia","volume":"357","author":"Brunzell","year":"2007","journal-title":"N Engl J Med"},{"key":"10.4158\/ACCR-2020-0191_bb0080","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2710.2000.00315.x","article-title":"Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients","volume":"25","author":"Kiortsis","year":"2000","journal-title":"J Clin Pharm Ther"},{"key":"10.4158\/ACCR-2020-0191_bb0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/VHRM.S158641","article-title":"Nonadherence to statins: individualized intervention strategies outside the pill box","volume":"14","author":"Lansberg","year":"2018","journal-title":"Vasc Health Risk Manag"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060520306222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060520306222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:31:57Z","timestamp":1762497117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060520306222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2376060520306222"],"URL":"https:\/\/doi.org\/10.4158\/accr-2020-0191","relation":{},"ISSN":["2376-0605"],"issn-type":[{"value":"2376-0605","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe Hypertriglyceridemia Associated With Everolimus Treatment After Heart Transplantation","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/ACCR-2020-0191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}